Literature DB >> 17488721

The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death.

Syed Mohammad Moin1, Milena Panteva, Shahid Jameel.   

Abstract

The biology and pathogenesis of hepatitis E virus are poorly understood due to the lack of an in vitro culture or infection models. The viral Orf3 protein activates the cellular mitogen-activated protein kinase pathway and is likely to modulate the host cell environment for efficient viral replication. We screened for cellular genes whose transcription was differentially up-regulated in an Orf3-expressing stable cell line (ORF3/4). The gene for mitochondrial voltage-dependent anion channel (VDAC) was one such candidate. The up-regulation of VDAC in ORF3/4 cells was confirmed by Northern and Western blotting in various cell lines. Transfection of ORF3/4 cells with an ORF3-specific small interfering RNA led to a reduction in VDAC protein levels. VDAC is a critical mitochondrial outer membrane protein, and its overexpression results in apoptosis. Surprisingly, Orf3-expressing cells were protected against staurosporine-induced cell death by preservation of mitochondrial potential and membrane integrity. A small interfering RNA-mediated reduction in Orf3 and VDAC levels also made cells sensitive to staurosporine. Chemical cross-linking showed Orf3-expressing cells to contain higher levels of oligomeric VDAC. These cells also contained higher levels of hexokinase I that directly interacted with VDAC. This interaction is known to preserve mitochondrial potential and prevent cytochrome c release. We report here the first instance of a viral protein promoting cell survival through such a mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488721      PMCID: PMC2440810          DOI: 10.1074/jbc.M701696200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis.

Authors:  John G Pastorino; Nataly Shulga; Jan B Hoek
Journal:  J Biol Chem       Date:  2001-12-18       Impact factor: 5.157

Review 2.  The voltage-dependent anion channel: an essential player in apoptosis.

Authors:  Yoshihide Tsujimoto; Shigeomi Shimizu
Journal:  Biochimie       Date:  2002 Feb-Mar       Impact factor: 4.079

Review 3.  Mitochondrion-targeted apoptosis regulators of viral origin.

Authors:  Patricia Boya; Thomas Roumier; Karine Andreau; Rosa Ana Gonzalez-Polo; Naoufal Zamzami; Maria Castedo; Guido Kroemer
Journal:  Biochem Biophys Res Commun       Date:  2003-05-09       Impact factor: 3.575

4.  Cell biology. NO says yes to mitochondria.

Authors:  Guy C Brown
Journal:  Science       Date:  2003-02-07       Impact factor: 47.728

5.  Cell biology: metabolism meets death.

Authors:  Julian Downward
Journal:  Nature       Date:  2003-08-21       Impact factor: 49.962

6.  The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase.

Authors:  Anindita Kar-Roy; Hasan Korkaya; Ruchi Oberoi; Sunil Kumar Lal; Shahid Jameel
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

7.  Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2.

Authors:  P H Schlesinger; A Gross; X M Yin; K Yamamoto; M Saito; G Waksman; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

8.  Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention.

Authors:  Peter L Pedersen; Saroj Mathupala; Annette Rempel; J F Geschwind; Young Hee Ko
Journal:  Biochim Biophys Acta       Date:  2002-09-10

9.  In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death.

Authors:  Heftsi Azoulay-Zohar; Adrian Israelson; Salah Abu-Hamad; Varda Shoshan-Barmatz
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

Review 10.  Hexokinase II: the integration of energy metabolism and control of apoptosis.

Authors:  John G Pastorino; Jan B Hoek
Journal:  Curr Med Chem       Date:  2003-08       Impact factor: 4.530

View more
  32 in total

1.  PKCε promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria.

Authors:  Eric Lau; Harriet Kluger; Tal Varsano; KiYoung Lee; Immo Scheffler; David L Rimm; Trey Ideker; Ze'ev A Ronai
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

Review 2.  Hepatitis e: molecular virology and pathogenesis.

Authors:  Subrat K Panda; Satya P K Varma
Journal:  J Clin Exp Hepatol       Date:  2013-05-30

3.  The PSAP motif within the ORF3 protein of an avian strain of the hepatitis E virus is not critical for viral infectivity in vivo but plays a role in virus release.

Authors:  Scott P Kenney; R S Pudupakam; Yao-Wei Huang; F William Pierson; Tanya LeRoith; Xiang-Jin Meng
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

4.  Hepatitis E virus replication requires an active ubiquitin-proteasome system.

Authors:  Yogesh A Karpe; Xiang-Jin Meng
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

5.  Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif.

Authors:  Suzanne U Emerson; Hanh T Nguyen; Udana Torian; Danielle Burke; Ronald Engle; Robert H Purcell
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

6.  RNA interference induces effective inhibition of mRNA accumulation and protein expression of SHEV ORF3 gene in vitro.

Authors:  Tao Liu; Ming Lei; Hanwei Jiao; Li Du; Ying Cheng; Donglin Zhang; Yongchang Hao; Churiga Man; Fengyang Wang
Journal:  Curr Microbiol       Date:  2011-01-12       Impact factor: 2.188

7.  Intergenotypic chimeric hepatitis E viruses (HEVs) with the genotype 4 human HEV capsid gene in the backbone of genotype 3 swine HEV are infectious in pigs.

Authors:  Alicia R Feagins; Laura Córdoba; Brent J Sanford; Barbara A Dryman; Yao-Wei Huang; Tanya LeRoith; Suzanne U Emerson; Xiang-Jin Meng
Journal:  Virus Res       Date:  2010-12-30       Impact factor: 3.303

Review 8.  Therapeutic targets for the treatment of hepatitis E virus infection.

Authors:  Scott P Kenney; Xiang-Jin Meng
Journal:  Expert Opin Ther Targets       Date:  2015-06-13       Impact factor: 6.902

9.  Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target.

Authors:  Changbo Qu; Shaoshi Zhang; Wenshi Wang; Meng Li; Yijin Wang; Marieke van der Heijde-Mulder; Ehsan Shokrollahi; Mohamad S Hakim; Nicolaas J H Raat; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  FASEB J       Date:  2018-08-02       Impact factor: 5.191

10.  The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response.

Authors:  Vivek Chandra; Anindita Kar-Roy; Sudha Kumari; Satyajit Mayor; Shahid Jameel
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.